Skip to main content

Original Research

Original Research
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression
Kimberly J. Reid, MS, Kathleen M. Aguilar, MPH, Eric Thompson, MBA, Ross M. Miller, MD, MPH
Stakeholder Perspective
Counting on a Run of Value-Based Benefit Design
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Original Research
Cardiovascular-Related Healthcare Resource Utilization and Costs in Patients with Hypertension Switching from Metoprolol to Nebivolol
Stephanie Chen, PhD, An-Chen Fu, MS, BSPharm, Rahul Jain, PhD, Hiangkiat Tan, MS, BSPharm
Stakeholder Perspective
Moving Beyond Measures into Outcomes in Hypertension Research
by Michael F. Murphy, MD, PhD
Read More
Original Research
Is Response-Guided Therapy Being Applied in the Clinical Setting? The Hepatitis C Example
Jennifer B Harris, PharmD, Phil Schwab, PhD, Melea A. Ward, PharmD, MS
Stakeholder Perspective
Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
by Jack E. Fincham, PhD, RPh
Read More
Original Research
Diagnosis and Treatment of Bipolar Disorders in Adults: A Review of the Evidence on Pharmacologic Treatments
Michael W Jann, PharmD
Stakeholder Perspective
Bipolar Disorders: Balancing Formulary Management and Clinical Outcomes for a Vulnerable Patient Population
by Gary M. Owens, MD
Read More
Original Research
Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting
Jennifer Cai, MS, MPH, Winghan Jacqueline Kwong, PharmD, PhD, Ronald Preblick, PharmD, MPH, Qiaoyi Zhang, MD, PhD
Stakeholder Perspective
Better Compliance with Clinical Guidelines for Venous Thromboembolism Can Improve Patient Outcomes, Reduce Costs
by James T. Kenney, RPh, MBA
Read More
Original Research
New and Emerging Drugs and Targets for Type 2 Diabetes: Reviewing the Evidence
Charles Jia-Haur Hu, DO, Chihyi Lin, DO, Brien Rex Miller, DO, Hanh Nguyen, DO, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Addressing Adherence a Key Challenge in the Management of Patients with Type 2 Diabetes
by Jeffrey A. Bourret, PharmD
Read More
Original Research
Evaluation of Dabigatran for Appropriateness of Use and Bleeding Events in a Community Hospital Setting
Anastasia L Armbruster, PharmD, BCPS, Katie S Buehler, PharmD, BCPS, Sun H Min, PharmD, Margaret Riley, PharmD, Michael W Daly, PharmD, MSCI, BCPS
Stakeholder Perspective
Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation
by Raymond L. Singer, MD, MMM, CPE
Read More
Original Research
Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer
Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA
Stakeholder Perspective
Predicting Behavior: It’s a Matter of Preference
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Original Research
Cardiovascular Events and Safety Outcomes Associated with Azithromycin Therapy: A Meta-Analysis of Randomized Controlled Trials
Ziyad S. Almalki, BPharm, PhD candidate, Jeff Jianfei Guo, BPharm, PhD
Stakeholder Perspective
Cardiovascular Safety of Azithromycin Therapy: Revisiting the Evidence
by Raymond L. Singer, MD, MMM, CPE
Read More
Original Research
Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults with Irritable Bowel Syndrome with Constipation: Results from 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
Jessica L. Buono, MPH, Robyn T. Carson, MPH, Jeffrey M. Johnston, MD, Phil Sarocco, RPh, MSc, Stavros Tourkodimitris, PhD
Stakeholder Perspective
Patient-Reported Outcomes Matter
by Walid F. Gellad, MD, MPH
Read More
Page 14 of 21
Results 131 - 140 of 209